Published in Sci Rep on March 20, 2015
The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Glycobiology (2015) 0.91
Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3. Proc Natl Acad Sci U S A (2016) 0.81
MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction. Int J Mol Sci (2016) 0.77
Lactobacillus plantarum displaying CCL3 chemokine in fusion with HIV-1 Gag derived antigen causes increased recruitment of T cells. Microb Cell Fact (2015) 0.76
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell (1997) 4.44
Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol (2005) 3.82
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A (2003) 3.77
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol (1998) 3.66
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol (2004) 3.66
Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat Immunol (2001) 3.38
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07
Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat Immunol (2005) 3.07
Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. Blood (1990) 3.02
Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 2.87
Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol (2014) 2.71
Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol (1992) 2.61
Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem (2005) 2.57
Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 2.00
Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J Immunol (2003) 1.95
Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed) (2009) 1.87
Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol (1996) 1.84
Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem (1998) 1.84
Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol (2005) 1.77
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms. J Cell Biol (2008) 1.75
The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem (2000) 1.73
Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry (1998) 1.71
Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J Biol Chem (2004) 1.69
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62
Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood (2004) 1.50
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J Biol Chem (2002) 1.46
Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem (2002) 1.44
The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure (2004) 1.42
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol (2004) 1.39
Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry (1995) 1.38
Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol (1995) 1.38
Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry (2001) 1.28
Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem (2005) 1.24
Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol (2010) 1.23
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. J Mol Cell Cardiol (2009) 1.20
Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. J Immunol (2005) 1.20
Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev (2005) 1.19
Aggregation of RANTES is responsible for its inflammatory properties. Characterization of nonaggregating, noninflammatory RANTES mutants. J Biol Chem (1999) 1.16
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. EMBO J (2010) 1.16
Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood (2003) 1.11
Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data. Structure (2011) 1.05
Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. J Invest Dermatol (1991) 1.03
A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry (2002) 1.00
Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ Res (1998) 1.00
Chemokines and the signaling modules regulating integrin affinity. Front Immunol (2012) 0.95
10E4 antigen of Scrapie lesions contains an unusual nonsulfated heparan motif. J Biol Chem (2001) 0.92
Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1). J Biol Chem (2012) 0.92
A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors. J Leukoc Biol (2001) 0.90
Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine. J Biol Chem (2014) 0.89
Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol Med (2014) 0.88
Ultrastructural localization of the intercellular adhesion molecule (ICAM-1) on the cell surface of high endothelial venules in lymph nodes. Anat Rec (1996) 0.88
Chemokine oligomerization in cell signaling and migration. Prog Mol Biol Transl Sci (2013) 0.83
A chemokine self-presentation mechanism involving formation of endothelial surface microstructures. J Immunol (2013) 0.82
Dances with leukocytes: how tetraspanin-enriched microdomains assemble to form endothelial adhesive platforms. J Cell Biol (2008) 0.80
Electron microscopy of endothelial microvilli of large arteries. Anat Rec (1975) 0.79